Revolution Medicines (RVMD) Market Cap to FCF (2020 - 2026)
Revolution Medicines (RVMD) Market Cap to FCF (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Market Cap to FCF |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - | -876,453.98 |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - | -49,404.47 |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | -103,827.99 |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 380.55 |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn | 33.24 |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn | 17.05 |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - | -6,062.98 |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 58.55 |
| 10 | Revolution Medicines | 37.56 Bn | 37.56 Bn | - | -35.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 23, 2026 | -35.26 |
| Jul 22, 2026 | -34.20 |
| Jul 21, 2026 | -34.24 |
| Jul 20, 2026 | -33.70 |
| Jul 17, 2026 | -34.78 |
| Jul 16, 2026 | -33.48 |
| Jul 15, 2026 | -34.46 |
| Jul 14, 2026 | -34.56 |
| Jul 13, 2026 | -34.37 |
| Jul 10, 2026 | -34.91 |
| Jul 9, 2026 | -35.71 |
| Jul 8, 2026 | -35.45 |
| Jul 7, 2026 | -35.58 |
| Jul 6, 2026 | -35.50 |
| Jul 2, 2026 | -35.36 |
| Jul 1, 2026 | -35.03 |
| Jun 30, 2026 | -34.99 |
| Jun 29, 2026 | -35.99 |
| Jun 26, 2026 | -34.02 |
| Jun 25, 2026 | -33.29 |